Discovery and Targeting of the Signaling Controls of <i>PNPLA3</i> to Effectively Reduce Transcription, Expression, and Function in Pre-Clinical NAFLD/NASH Settings
Non-alcoholic fatty liver disease (NAFLD) and non-alcoholic steatohepatitis (NASH) are emerging worldwide epidemics, projected to become the leading cause of liver transplants. The strongest genetic risk factor for NAFLD/NASH susceptibility and progression is a single-nucleotide polymorphism (SNP) i...
Main Authors: | Brian E. Schwartz, Vaishnavi Rajagopal, Cynthia Smith, Evan Cohick, Gavin Whissell, Mario Gamboa, Rutuja Pai, Alla Sigova, Iris Grossman, David Bumcrot, Kavitha Sasidharan, Stefano Romeo, Alfica Sehgal, Piero Pingitore |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-10-01
|
Series: | Cells |
Subjects: | |
Online Access: | https://www.mdpi.com/2073-4409/9/10/2247 |
Similar Items
-
CYT387, a potent IKBKE inhibitor, suppresses human glioblastoma progression by activating the Hippo pathway
by: Xin Wang, et al.
Published: (2021-09-01) -
Evaluating the Safety, Efficacy, and Therapeutic Potential of Momelotinib in the Treatment of Intermediate/High-Risk Myelofibrosis: Evidence to Date
by: Bassiony S, et al.
Published: (2020-09-01) -
Clinical-morphological parallels of the PNPLA3 gene polymorphism in patients with nonalcoholic fatty liver disease
by: A S Tikhomirova, et al.
Published: (2018-02-01) -
Additive Effects of the Risk Alleles of PNPLA3 and TM6SF2 on Nonalcoholic Fatty Liver Disease (NAFLD) in a Chinese Population
by: Xiaoliang Wang, et al.
Published: (2016-08-01) -
Monozygotic twins with NASH cirrhosis: cumulative effect of multiple single nucleotide polymorphisms?
by: Jane I. Grove, et al.
Published: (2016-03-01)